The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Van Houte Hans since 2021.
This trader's CIK number is 1817217.
At the time of last reporting, Van Houte Hans was the Chief Financial Officer of Nurix Therapeutics, Inc.. (stock ticker symbol NRIX).
Also see all insider trading activities at Nurix Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | NRIX | 0 | $0 | 26,978 | $351,988 | 28,766 | $0 |
| 2024 | NRIX | 0 | $0 | 63,863 | $1,302,028 | 22,158 | $0 |
| 2023 | NRIX | 0 | $0 | 18,417 | $180,148 | 15,544 | $0 |
| 2022 | NRIX | 0 | $0 | 2,188 | $29,491 | 76,991 | $57,399 |
| 2021 | NRIX | 0 | $0 | 54,332 | $2,115,857 | 54,332 | $138,686 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-01 | NRIX | Sale | 5,402 | 11.03 | 59,600 |
| 2025-07-30 | NRIX | Option Ex | 11,494 | .00 | 0 |
| 2025-07-30 | NRIX | Sale | 4,304 | 12.01 | 51,695 |
| 2025-05-02 | NRIX | Sale | 6,198 | 11.33 | 70,241 |
| 2025-04-30 | NRIX | Sale | 2,438 | 11.50 | 28,041 |
| 2025-04-30 | NRIX | Option Ex | 8,636 | .00 | 0 |
| 2025-03-03 | NRIX | Sale | 5,825 | 14.77 | 86,006 |
| 2025-01-30 | NRIX | Sale | 2,811 | 20.07 | 56,405 |
| 2025-01-30 | NRIX | Option Ex | 8,636 | .00 | 0 |
| 2024-11-01 | NRIX | Sale | 3,546 | 24.28 | 86,082 |
| 2024-10-30 | NRIX | Option Ex | 8,636 | .00 | 0 |
| 2024-10-30 | NRIX | Sale | 2,368 | 24.30 | 57,554 |
| 2024-08-26 | NRIX | Sale | 20,000 | 25.22 | 504,380 |
| 2024-08-01 | NRIX | Sale | 3,477 | 21.82 | 75,878 |
| 2024-07-30 | NRIX | Option Ex | 8,636 | .00 | 0 |
| 2024-07-30 | NRIX | Sale | 2,490 | 20.67 | 51,463 |
| 2024-06-20 | NRIX | Sale | 20,000 | 20.01 | 400,220 |
| 2024-05-02 | NRIX | Sale | 3,499 | 12.83 | 44,878 |
| 2024-02-16 | NRIX | Sale | 6,812 | 10.02 | 68,222 |
| 2024-01-30 | NRIX | Option Ex | 4,886 | .00 | 0 |
| 2024-01-30 | NRIX | Sale | 1,671 | 7.99 | 13,351 |
| 2023-12-20 | NRIX | Sale | 3,541 | 10.00 | 35,420 |
| 2023-12-19 | NRIX | Sale | 10,906 | 10.00 | 109,092 |
| 2023-10-30 | NRIX | Option Ex | 4,886 | .00 | 0 |
| 2023-10-31 | NRIX | Sale | 1,080 | 5.20 | 5,612 |
| 2023-07-30 | NRIX | Option Ex | 4,886 | .00 | 0 |
| 2023-07-31 | NRIX | Sale | 1,245 | 9.65 | 12,020 |
| 2023-05-01 | NRIX | Sale | 721 | 9.88 | 7,120 |
| 2023-04-30 | NRIX | Option Ex | 2,886 | .00 | 0 |
| 2023-01-30 | NRIX | Option Ex | 2,886 | .00 | 0 |
| 2023-01-30 | NRIX | Sale | 924 | 11.78 | 10,884 |
| 2022-10-31 | NRIX | Sale | 739 | 12.88 | 9,519 |
| 2022-10-30 | NRIX | Option Ex | 2,886 | .00 | 0 |
| 2022-08-01 | NRIX | Sale | 752 | 15.67 | 11,783 |
| 2022-07-30 | NRIX | Option Ex | 2,886 | .00 | 0 |
| 2022-05-31 | NRIX | Option Ex | 68,333 | .84 | 57,399 |
| 2022-04-30 | NRIX | Option Ex | 2,886 | .00 | 0 |
| 2022-05-02 | NRIX | Sale | 697 | 11.75 | 8,189 |
| 2021-02-24 | NRIX | Sale | 35,419 | 39.90 | 1,413,218 |
| 2021-02-24 | NRIX | Option Ex | 35,419 | 3.44 | 121,841 |
| 2021-02-22 | NRIX | Option Ex | 5,330 | 1.02 | 5,436 |
| 2021-02-22 | NRIX | Sale | 5,330 | 39.93 | 212,837 |
| 2021-02-18 | NRIX | Option Ex | 13,583 | .84 | 11,409 |
| 2021-02-18 | NRIX | Sale | 13,583 | 36.06 | 489,802 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Van Houte Hans (Chief Financial Officer of Nurix Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.